Physician profile
Jack Komro
NPI 1134700719
$2,642.76
in general payments reported to CMS, 2019-2025
10 companies · $438 in 2025
The $438 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $689 · 2023: $476 · 2024: $1,040 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,953.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $712.82 | 2023-2025 | Hydrus Microstent, Luxor, Clareon |
| Amgen INC. | $238.88 | 2024-2025 | Tepezza |
| Abbvie INC. | $234.86 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $223.58 | 2024 | Eylea Hd |
| Stryker Corporation | $159.73 | 2025 | Na |
| Sight Sciences, INC. | $121.91 | 2024 | Omni Surgical System |
| Dompe US, INC. | $120.56 | 2024 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $97.96 | 2024 | Idesign Rs, Wavescan Wavefront System, Star S4 Ir |
| Argenx US, INC. | $22.95 | 2025 | Vyvgart, Vyvgart Hytrulo |
| Ani Pharmaceuticals, INC. | $20.35 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Komro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.